We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

48 hedge funds and large institutions have $191M invested in Applied Genetic Technologies Corporation in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

84% more capital invested

Capital invested by funds: $104M → $191M (+$87M)

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

14% more funds holding

Funds holding: 4248 (+6)

Holders
48
Holders Change
+6
Holders Change %
+14.29%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
17
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
51
Spark Investment Management
New York
-$191K -10,300 Closed
SO
52
STRS Ohio
Ohio
-$32K -1,700 Closed
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
-$3.48K -187 Closed
Federated Hermes
54
Federated Hermes
Pennsylvania
-$1K -61 Closed

AGTC Hedge Fund Activity: Q4 2014 in Review

48 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2014, worth a combined $191M — up 84% from $104M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AGTC positions and 6 closed out — a net gain of 7 holders — while 17 added to existing stakes and 11 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $11.8M. The largest seller was Sphera Funds Management, cutting an estimated $929K.

  • 48 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2014, up from 42 in Q3 2014.
  • Funds reported $191M of Applied Genetic Technologies Corporation stock for Q4 2014, up 84% quarter-over-quarter.
  • 13 funds opened new Applied Genetic Technologies Corporation positions in Q4 2014 and 6 closed out, a net change of +7 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2014 was Fidelity Investments, an estimated $11.8M added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2014 was Sphera Funds Management, an estimated $929K sold.

Based on aggregated 13F filings for Q4 2014.